Post by bioMérieux

🧱 Today, we officially broke ground on a new manufacturing facility in France (La Balme-les-Grottes, Isère), dedicated to our BIOFIRE® PCR diagnostic solutions. This site will play a key role in securing the supply of essential diagnostic solutions for the European market and supporting bioMérieux’s long-term growth. The molecular tests produced at La Balme will enable the rapid and reliable identification of the main causes of infectious diseases. Designed to complement our U.S.-based manufacturing operations, this new facility strengthens the resilience and agility of our global production network. It will help us better serve patients wherever they are, driven by our commitment to making the world a healthier place. 📰 Read the full press release: http://spkl.io/604376QYT